Dynamic contrast-enhanced MRI texture analysis for pretreatment prediction of clinical and pathological response to neoadjuvant chemotherapy in patients with locally advanced breast cancer-Reference-Cited by-同舟云学术

Dynamic contrast-enhanced MRI texture analysis for pretreatment prediction of clinical and pathological response to neoadjuvant chemotherapy in patients with locally advanced breast cancer

Published:2014-05-20 Issue:8 Volume:27 Page:887-896
ISSN:0952-3480
Container-title:NMR in Biomedicine
language:en
Short-container-title:NMR Biomed.

Author:

Teruel Jose R.¹²,Heldahl Mariann G.¹,Goa Pål E.³⁴,Pickles Martin⁵,Lundgren Steinar⁶⁷,Bathen Tone F.¹²,Gibbs Peter⁵

Affiliation:

1. Department of Circulation and Medical Imaging; Norwegian University of Science and Technology (NTNU); Trondheim Norway

2. St. Olavs Hospital; Trondheim University Hospital; Trondheim Norway

3. Clinic of Radiology and Nuclear Medicine; St. Olavs Hospital, Trondheim University Hospital; Trondheim Norway

4. Department of Physics; Norwegian University of Science and Technology (NTNU); Trondheim Norway

5. Centre for Magnetic Resonance Investigations; Hull York Medical School at University of Hull; Hull UK

6. Department of Oncology, St. Olavs Hospital; Trondheim University Hospital; Trondheim Norway

7. Department of Cancer Research and Molecular Medicine; Norwegian University of Science and Technology (NTNU); Trondheim Norway

Funder

Central Norway Regional Health Authority (RHA)

Liaison Committee between the RHA and the Norwegian University of Science and Technology (NTNU)

NTNU Strategic Area of Medical Technology

Publisher

Wiley

Subject

Spectroscopy,Radiology, Nuclear Medicine and imaging,Molecular Medicine

Reference38 articles.

1. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11;Ferlay;Int. Agency Res. Cancer,2013

2. Locally advanced and inflammatory breast cancer;Chia;J. Clin. Oncol.,2008

3. Neoadjuvant therapy for breast cancer;Liu;J. Surg. Oncol.,2010

4. Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy;Kuerer;J. Clin. Oncol.,1999

5. Outcome after pathologic complete eradication of cytologically proven breast cancer axillary node metastases following primary chemotherapy;Hennessy;J. Clin. Oncol.,2005

Cited by 111 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Texture analysis using non-contrast MRI to predict estrogen receptor status in breast cancer lesions: Is it feasible?;Clinical Radiology;2024-07

2. Exploring Neoadjuvant Chemotherapy, Predictive Models, Radiomic, and Pathological Markers in Breast Cancer: A Comprehensive Review;Cancers;2023-11-04

3. Radiomic Nomogram for Predicting Axillary Lymph Node Metastasis in Patients with Breast Cancer;Academic Radiology;2023-11

4. Enhanced full-inversion-based ultrasound elastography for evaluating tumor response to neoadjuvant chemotherapy in patients with locally advanced breast cancer;Physica Medica;2023-08

5. Can magnetic resonance imaging texture analysis change the breast imaging reporting and data system category of breast lesions?;Clinical Imaging;2023-05